MK-677 has been shown to cause significant increases in GH and IGF-1 levels, with only a transient effect on cortisol and prolactin
Compounded formulations of these medications available through telehealth platforms have not undergone this same FDA approval process
Martin Lange, Executive Vice President for Development at Novo Nordisk, stated, We remain committed to the potential of once-weekly basal insulin icodec for individuals managing diabetes who require basal insulin therapy
Between Q4 2024 and Q1 2025, the share of Medicare patients with comorbid diabetes or obesity and MASLD who started a GLP1 rose from 13% to 19%, compared with only a modest increase from 20% to 22% among commercially insured patients
It helps reduce signs of aging and boost skin renewal
JCI Insight 5 , e140532 (2020)